Exodus Point Capital Management, LP Aytu Biopharma, Inc Transaction History

Exodus Point Capital Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.35 - $2.95 $21,586 - $47,170	-15,990 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.78 - $5.12 $105,275 - $193,889	-37,869 Reduced 70.31%	15,990 $46,000
Q2 2021 Aug 16, 2021	BUY	$4.73 - $7.56 $254,753 - $407,174	53,859 New	53,859 $270,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $97.4M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.